April 1 (Reuters) - Mesoblast Ltd MSB.AX :
* Cell therapy shows disease modifying effects on knee osteoarthritis
* Trial met its primary safety and secondary efficacy endpoints Source text for Eikon: ID:nGNXMQHOFa Further company coverage: MSB.AX
(Bengaluru Newsroom: +1 646 223 8780)